▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1258 by analyst upside · 2026-08-13
CTNM
Contineum Therapeutics, Inc.
Healthcare · Market Cap $564M · P/E 0x
ANALYST PRICE TARGET
+52.6%
implied upside to consensus target
Current Price $14.98
Consensus Target $22.86
Bull Target $28.0
Bear Target $16.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
1
Sell
0
52-Week Low $6.56
52-Week High $16.91
YTD Return +31.5%
FUNDAMENTALS
Market Cap $564M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.72
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $6.56
52-Week High $16.91
Current Price $14.98
Bear Target $16.0
Bull Target $28.0
● Now $14.98 ● Target $22.86
TRADING DATA
Avg Volume 333K
YTD Return +31.5%
Analyst Count 7
Consensus Buy
Upside to Target +52.6%
Last Updated 2026-08-13

ANALYST SUMMARY

Contineum Therapeutics, Inc. (CTNM) is currently trading at $14.98 with a Wall Street consensus price target of $22.86, implying potential upside of 52.6% over the next 12 months. 7 analysts currently cover CTNM, with a consensus rating of Buy - 86% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $28.0, while the most cautious has a target of $16.0.

CTNM operates in the Healthcare sector with a market capitalisation of $564M. The stock is up 31.5% year-to-date and is currently trading near the upper end of its 52-week range of $6.56 – $16.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

GMRS +50.7%
GMR Solutions Inc.
$695M · P/E 6.7x · Buy
IRWD +41.2%
Ironwood Pharmaceuticals, Inc.
$714M · P/E 5.5x · Buy
TCMD +56.1%
Tactile Systems Technology, Inc.
$555M · P/E 22.9x · Buy
RIGL +32.8%
Rigel Pharmaceuticals, Inc.
$782M · P/E 2.5x · Buy
CYH +9.2%
Community Health Systems, Inc.
$410M · P/E 1.6x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for CTNM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-05-14 Building track record
Baird - Reiterated
Outperform → Outperform 2026-03-06 Building track record
Morgan Stanley ↓ Downgrade
Overweight → Equal-Weight 2026-01-08 Building track record
Baird - Reiterated
Outperform → Outperform 2025-11-24 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2025-11-21 Building track record
Leerink Partners ● Initiated
Outperform 2025-09-25 29% win rate (7 calls)
Morgan Stanley - Reiterated
Overweight → Overweight 2025-08-18 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2025-05-19 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
52
out of 100
Coverage depth
16/30
Consensus clarity
14/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →